CONSULTORIO | ¿Hasta cuándo hay que aguantar IAG? Tiene un objetivo ambicioso
Listen now
Description
David Galán, responsable de renta variable de Bolsa General, analiza las acciones de IAG, Solaria, Merck, Novo Nordisk, Hims & Hers Health.
More Episodes
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
